300642.SZ
透景生命
SZSE · Healthcare · C 制造业 · CN
CNY 13.50
−1.53%Year over year
Reported trailing growth
- Revenue
- -11.2%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +43.6%
- Operating cash flow
- -11.0%
Forward estimates
Based on analyst estimates
- Revenue
- +122.4%
- EBITDA
- +452.2%
- EPS
- +7936.2%
Three-year CAGR
- Revenue
- -20.2%
- EBITDA
- -34.5%
- EBIT
- —
- Net income
- -69.4%
- EPS
- -69.4%
- Free cash flow
- -8.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026